Introduction
Cerebral Ischemia Reperfusion (I/R) injury occurs when blood flow returns to the brain after a stroke, triggering a cascade of cellular damage. A significant contributor to this damage is ferroptosis—a form of regulated cell death driven by iron-dependent lipid peroxidation. Research published in Molecular Neurobiology (2022) explored how the COX-2/PGE2 signaling pathway modulates this process, specifically focusing on the expression of prostaglandin E2 (PGE2) receptors.
The Nature of the Correction
The authors recently issued a formal correction regarding Figure 6 of the original manuscript. During the assembly of the final figures, the "actin" protein bands in Figure 6C, which serve as a critical loading control for Western blotting, were inadvertently mixed up. This correction provides the accurate visual data, ensuring that the reported changes in protein expression are validated against consistent loading controls. In Western blotting, actin is used to prove that the same amount of total protein was loaded into every lane, making its accuracy essential for interpreting biological signals.
Key Experimental Findings
The study utilized a combination of RT-qPCR and Western blotting to examine the expression of PGE2 receptors (EP1, EP2, EP3, and EP4) under various conditions. The experimental groups included sham controls and I/R injury models, both with and without the ferroptosis inhibitor Ferrostatin-1 (Fer-1).
Receptor Dynamics and Ferroptosis
As shown in Figure 6A, I/R injury leads to a dramatic increase in the mRNA levels of the EP3 receptor (approximately 6-fold) and a notable increase in EP2. Interestingly, treatment with Fer-1 significantly attenuated the spike in EP3 mRNA levels. This suggests a feedback loop where ferroptosis and PGE2 receptor signaling are interconnected during brain injury.
Protein Expression Validation
The corrected Western blots in panels B and C confirm that the protein levels of EP3 and EP4 also increase following I/R injury. By rectifying the actin loading control in panel C, the authors demonstrate that these observed increases are biologically significant and not the result of uneven protein loading across samples. The results show that these increases are modulated when ferroptosis is inhibited by Fer-1, further supporting the pathway's role in the injury response.
Conclusion
While the core conclusions of the original study remain unchanged, this correction is vital for maintaining scientific integrity. The accurate data reinforces the role of the COX-2/PGE2 pathway, specifically through receptors like EP3 and EP4, in the response to cerebral ischemia-induced ferroptosis.
Summary updated